{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:54:41Z","timestamp":1790884481747,"version":"4.1.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"28","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,10]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting reproductive-aged women and is associated with an increased risk of early pregnancy loss (EPL). The underlying mechanisms remain multifactorial and poorly understood. This study aimed to identify key risk factors for EPL in PCOS patients and develop a corresponding predictive model. A retrospective and observational cohort study was conducted on 134 PCOS patients between January 2023 and June 2025. Patients were randomly assigned to training (60%, n\u2005=\u200580) and validation (40%, n\u2005=\u200554) cohorts using an internal validation method. Clinical data, including patients\u2019 demographic and clinical factors (age, body mass index, history of adverse pregnancy outcomes), and laboratory test results (fasting blood glucose, fasting insulin(FINS), impaired glucose tolerance, triglyceride(TG), total cholesterol, high-density lipoprotein cholesterol(HDL-C), thyroid-stimulating hormone, anti-m\u00fcllerian hormone(AMH), vitamin D(VD), estradiol, progesterone, luteinizing hormone (LH), follicle-stimulating hormone, prolactin and testosterone), were collected and analyzed. Univariable and multivariable logistic regression identified independent risk factors, which were incorporated into a nomogram prediction model. Model performance was assessed using the C-index, receiver operating characteristic curves, calibration plots, and decision curve analysis. Univariable logistic analysis revealed statistical differences between the EPL group and non-EPL group in body mass index, FINS, LH, LH\/FSH, PRL, Testo, AMH, and VD (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;.05). Multivariable logistic analysis identified FINS, LH, Testo, and AMH as independent risk factors for EPL (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05). A nomogram prediction model incorporating these factors demonstrated strong performance, with C-indices of 0.869 (training cohort) and 0.860 (validation cohort), and AUC values of 0.869 and 0.860, respectively. Calibration curves showed good agreement between predicted and observed probabilities, and decision curve analysis confirmed the clinical utility and net benefit of the model. This study developed and validated a nomogram based on FINS, LH, Testo, and AMH for predicting EPL risk in PCOS patients. The model exhibits reasonable predictive accuracy and certain clinical applicability, offering a potential tool for early identification and personalized management of high-risk pregnancies. However, due to the limitations of a single-center study design and a relatively small sample size, the conclusions of this study still need to be validated through larger-scale clinical research before they can be applied in clinical practice.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049669","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T22:02:15Z","timestamp":1783720935000},"page":"e49669","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Risk factors and prediction model for early pregnancy loss in polycystic ovary syndrome \u2013 development and validation: A retrospective and observational study"],"prefix":"10.1097","volume":"105","author":[{"given":"Jingqi","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Gynecology, Xiamen Huli Renjun Hospital, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Xiamen Huli Renjun Hospital, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Xiamen Huli Renjun Hospital, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7923-5838","authenticated-orcid":false,"given":"Yongquan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Xiamen University Medical Center, Xiamen, Fujian, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261001","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome.","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"key":"R2-20261001","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/obr.12829","article-title":"Increased maternal pregnancy complications in polycystic ovary syndrome appear to be independent of obesity\u2014a systematic review, meta-analysis, and meta-regression.","volume":"20","author":"Bahri Khomami","year":"2019","journal-title":"Obes Rev"},{"key":"R3-20261001","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.tem.2016.11.008","article-title":"Oocyte competence in women with polycystic ovary syndrome.","volume":"28","author":"Palomba","year":"2017","journal-title":"Trends Endocrinol Metab"},{"key":"R4-20261001","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/humrep\/dew243","article-title":"Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic\u2013hyperinsulinaemic clamp studies.","volume":"31","author":"Cassar","year":"2016","journal-title":"Hum Reprod"},{"key":"R5-20261001","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/humupd\/dms030","article-title":"Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis.","volume":"18","author":"Lim","year":"2019","journal-title":"Hum Reprod Update"},{"key":"R6-20261001","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s10815-016-0720-6","article-title":"Immunogenetic contributions to recurrent pregnancy loss.","volume":"33","author":"Grimstad","year":"2016","journal-title":"J Assist Reprod Genet"},{"key":"R7-20261001","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13048-025-01654-x","article-title":"Construction and evaluation of machine learning-based prediction model for live birth following fresh embryo transfer in IVF\/ICSI patients with polycystic ovary syndrome.","volume":"18","author":"Zhu","year":"2025","journal-title":"J Ovarian Res"},{"key":"R8-20261001","doi-asserted-by":"crossref","first-page":"1689878","DOI":"10.3389\/fendo.2025.1689878","article-title":"Predictors of miscarriage in polycystic ovary syndrome patients with threatened abortion: development and validation of a nomogram model.","volume":"16","author":"Ma","year":"2026","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R9-20261001","doi-asserted-by":"crossref","first-page":"e4863","DOI":"10.1097\/MD.0000000000004863","article-title":"Association between polycystic ovary syndrome and the risk of pregnancy complications: a PRISMA-compliant systematic review and meta-analysis.","volume":"95","author":"Yu","year":"2016","journal-title":"Medicine (Baltim)"},{"key":"R10-20261001","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10815-022-02619-5","article-title":"Embryo classification beyond pregnancy: early prediction of first trimester miscarriage using machine learning.","volume":"40","author":"Amitai","year":"2023","journal-title":"J Assist Reprod Genet"},{"key":"R11-20261001","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.fertnstert.2014.08.001","article-title":"Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?","volume":"102","author":"Daan","year":"2019","journal-title":"Fertil Steril"},{"key":"R12-20261001","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.","volume":"33","author":"Teede","year":"2018","journal-title":"Hum Reprod"},{"key":"R13-20261001","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1093\/humrep\/det262","article-title":"Prevalence of polycystic ovary syndrome in women in China: a large community-based study.","volume":"28","author":"Li","year":"2023","journal-title":"Hum Reprod"},{"key":"R14-20261001","doi-asserted-by":"crossref","first-page":"RAF250160","DOI":"10.1530\/RAF-25-0160","article-title":"An early LH surge may jeopardize ART outcomes of patients with PCOS and its predictive models.","volume":"7","author":"Ji","year":"2026","journal-title":"Reprod Fertil"},{"key":"R15-20261001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4274\/jtgga.galenos.2021.2021-9-29","article-title":"Remote assessment and reinforcement of patient awareness of role of lifestyle modification and treatment adherence in polycystic ovary syndrome using an online video based educational module.","volume":"23","author":"Gour","year":"2022","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"R16-20261001","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1093\/humrep\/dew149","article-title":"Ovarian hyperstimulation syndrome: review and new classification criteria for reporting in clinical trials.","volume":"31","author":"Humaidan","year":"2016","journal-title":"Hum Reprod"},{"key":"R17-20261001","first-page":"e46859","article-title":"Type 2 diabetes mellitus in patients with polycystic ovary syndrome.","volume":"15","author":"Agrawal","year":"2023","journal-title":"Cureus"},{"key":"R18-20261001","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/humupd\/dmt062","article-title":"The physiology and clinical utility of anti-Mullerian hormone in women.","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"key":"R19-20261001","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1093\/eurheartj\/ehu207","article-title":"Towards better clinical prediction models: seven steps for development and an ABCD for validation.","volume":"35","author":"Steyerberg","year":"2020","journal-title":"Eur Heart J"},{"key":"R20-20261001","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12916-019-1466-7","article-title":"Calibration: the Achilles heel of predictive analytics.","volume":"17","author":"Van Calster","year":"2019","journal-title":"BMC Med"},{"key":"R21-20261001","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s41512-019-0064-7","article-title":"A simple, step-by-step guide to interpreting decision curve analysis.","volume":"3","author":"Vickers","year":"2019","journal-title":"Diagn Progn Res"},{"key":"R22-20261001","doi-asserted-by":"crossref","first-page":"g7594","DOI":"10.1136\/bmj.g7594","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement.","volume":"350","author":"Collins","year":"2019","journal-title":"BMJ"},{"key":"R23-20261001","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","article-title":"Nomograms in oncology: more than meets the eye.","volume":"16","author":"Balachandran","year":"2020","journal-title":"Lancet Oncol"},{"key":"R24-20261001","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fendo.2019.00023","article-title":"Follicle stimulating hormone receptor (FSHR) polymorphisms and polycystic ovary syndrome (PCOS).","volume":"10","author":"Laven","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R25-20261001","first-page":"CD003053","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.","volume":"2018","author":"Morley","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"R26-20261001","first-page":"CD013792","article-title":"Progestogens for preventing miscarriage: a network meta-analysis.","volume":"4","author":"Devall","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"R27-20261001","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3390\/diagnostics13030382","article-title":"Hormonal and metabolic factors influence the action of progesterone on the endometrium of women with polycystic ovary syndrome.","volume":"13","author":"Baracat","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"R28-20261001","doi-asserted-by":"crossref","first-page":"m441","DOI":"10.1136\/bmj.m441","article-title":"Calculating the sample size required for developing a clinical prediction model.","volume":"368","author":"Riley","year":"2020","journal-title":"BMJ"},{"key":"R29-20261001","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7326\/M18-1376","article-title":"PROBAST: a tool to assess the risk of bias and applicability of prediction model studies.","volume":"170","author":"Wolff","year":"2019","journal-title":"Ann Intern Med"},{"key":"R30-20261001","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1055\/s-0033-1356481","article-title":"Biomarkers of ovarian reserve in women with polycystic ovary syndrome.","volume":"31","author":"Huddleston","year":"2013","journal-title":"Semin Reprod Med"},{"key":"R31-20261001","doi-asserted-by":"crossref","first-page":"R141","DOI":"10.1530\/JOE-14-0296","article-title":"Androgen actions in the ovary: balance is key.","volume":"222","author":"Prizant","year":"2021","journal-title":"J Endocrinol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049669","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:01:44Z","timestamp":1790881304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":31,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049669","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"2025-11-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}